Trial · NCT03204188
Adverse events313
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 313
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 7 | 15 | 13 |
| other | Hepatosplenomegaly | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Iron deficiency anemia | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 2 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 4 |
| other | Fullness above his left collar bone | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Leukocytosis | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 2 |
| other | Lymph node pain | Blood and lymphatic system disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Atrial fibrillation | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | AV nodal disease | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Abnormal R-wave progression, early transition of QRS | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Coronary artery disease | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Non-specific T wave abnormalities | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Premature ventricular complex (PVC) | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Heart murmur | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Premature ventricular contractions | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Myocardial infarction | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Palpitations | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 3 | 15 | 5 |
| other | Pericardial effusion | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | 15 | 1 |
| other | Sinus bradycardia | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 3 | 15 | 6 |
| other | Sinus tachycardia | Cardiac disorders | Ibrutinib, Fludarabine, and Pembrolizumab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 5 | 15 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204188/events